Heart Disease Clinical Trials in Chicago

Showing 121-140 of 440 trials

A Study of Mavacamten in Participants With HFpEF and Elevation of NT-proBNP With or Without Elevation of cTnT

NCT04766892

This is a Phase 2a proof-of-concept study to assess safety, tolerability, and preliminary efficacy of mavacamten treatment on biomarker levels in participants with heart failure with preserved ejection fraction (HFpEF) and elevation of NT-proBNP with or without elevation of cTnT. Data from this study will inform future study designs of mavacamten in patients with HFpEF.

Heart Failure With Preserved Ejection Fraction

Bristol-Myers Squibb30 participantsStarted Mar 2021

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +18 more locations

Active Not RecruitingNA2.2 miles

PROACTIVE-HF IDE Trial Heart Failure NYHA Class III

NCT04089059

This is a prospective, open- label, single arm, multicenter clinical trial to evaluate the safety and effectiveness of the Cordella PA Sensor System in NYHA Class III Heart Failure Patients compared to a Performance Goal (PG).

Heart Failure NYHA Class III

Endotronix, Inc.738 participantsStarted Jan 2020

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Phoenix, Arizona, United States +71 more locations

A Study of Mavacamten in Participants With HFpEF and Elevation of NT-proBNP With or Without Elevation of cTnT

PROACTIVE-HF IDE Trial Heart Failure NYHA Class III

Heart Disease Trials in Other Cities

The Fluoroless-CSP Trial Using Electroanatomic Mapping

Benefits of µCor in Ambulatory Decompensated Heart Failure

Early Intervention to Promote Cardiovascular Health of Mothers and Children

FUnctional diagnoSIs of corONary Stenosis (FUSION)

Intracardiac CrYoablation for AtrioVentricular Nodal Reentrant Tachycardia

Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting

Benefits of Microcor in Ambulatory Decompensated Heart Failure

Efficacy and Safety of MEDI6570 in Patients With a History of Myocardial Infarction

Impact of Patient-Centered Approach for Communicating Coronary Calcium on Cardiovascular Health

Prognostic Impact of Cardiac Diastolic Function and Coronary Microvascular Function

Surveillance and Alert-based Multiparameter Monitoring to Reduce Worsening Heart Failure Events

Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction

The CorCinch - Functional Mitral Valve Regurgitation (FMR) Study

A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP)

Effect of Fetal Aortic Valvuloplasty on Outcomes

A Study to Evaluate the Safety of mRNA-0184 in Participants With Heart Failure

Communication During Hospitalization About Resuscitation Trial

Cardiovascular Risk Screening and Risk Reduction in Women Vets

Other Conditions in Chicago